Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gongzhi Wu
Observed name:
Wu, Gongzhi
Institution:
Lishui City People's Hospital
Observed institutions:
Wenzhou Medical University,
Lishui City People's Hospital
ORCID:
0000-0002-3767-1364
Observed ORCID:
0000-0002-3767-1364
OpenAlex ID:
A5054133993
MiR-129-2-3p Inhibits Esophageal Carcinoma Cell Proliferation, Migration, and Invasion via Targeting DNMT3B
2022
·
Huaizhong Zhang
, Xuyang Peng
, et al.
·
Current Molecular Pharmacology
·
28
miR-182-5p Serves as an Oncogene in Lung Adenocarcinoma through Binding to STARD13
2021
·
Xuhui Wu
, Wei Wang
, et al.
·
Computational and Mathematical Methods in Medicine
·
19
PDF
miR ‐126 regulates the proliferation, migration, invasion, and apoptosis of non‐small lung cancer cells via AKT2 / HK2 axis
2021
·
Bin Huang
, Gongzhi Wu
, et al.
·
IUBMB Life
·
18
MiR-196b Promotes the Invasion and Migration of Lung Adenocarcinoma Cells by Targeting AQP4
2021
·
Xuhui Wu
, Gongzhi Wu
, et al.
·
Technology in Cancer Research & Treatment
·
12
Identification of a dysregulated ceRNA network modulated by copy number variation‐driven lncRNAs in lung squamous cell carcinoma
2022
·
Jianyang Ding
, Mingjiang Huang
, et al.
·
Environmental and Molecular Mutagenesis
·
10
PLA2G2D fosters angiogenesis in non-small cell lung cancer through aerobic glycolysis
2024
·
Huaizhong Zhang
, Keng Chen
, et al.
·
Growth Factors
·
8
EZH2 affects malignant progression and DNA damage repair of lung adenocarcinoma cells by regulating RAI2 expression
2022
·
Mingjiang Huang
, Jianyang Ding
, et al.
·
Mutation research. Fundamental and molecular mechanisms of mutagenesis
·
5
TFDP1 activates SPC25-mediated glutamine metabolism to repress anti-tumor immunity of NK cells in lung adenocarcinoma
2025
·
Bin Huang
, Keng Chen
, et al.
·
Expert Review of Clinical Immunology
·
4
A Prospective Multicenter Comparative Cohort Study of Neoadjuvant Sintilimab Plus Chemotherapy and Chemoradiotherapy in Resectable Clinical Node-Positive Esophageal Squamous Cell Carcinoma
2026
·
Aizemaiti Rusidanmu
, Kun Zhou
, et al.
·
Annals of Surgical Oncology
·
1
ASO Visual Abstract: A Prospective Multicenter Comparative Cohort Study of Neoadjuvant Sintilimab Plus Chemotherapy and Chemoradiotherapy in Resectable Clinical Node-Positive Esophageal Squamous Cell Carcinoma
2026
·
Aizemaiti Rusidanmu
, Kun Zhou
, et al.
·
Annals of Surgical Oncology
The efficacy and safety of neoadjuvant sintilimab combined with chemotherapy in resectable locally advanced lymph node-positive esophageal squamous cell carcinoma: A real world study.
2024
·
Peng Ye
, Aizemaiti Rusidanmu
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
16
Citation count:
105
H-index:
6
I10-index:
5
Year
Topic
Type